Dan Wildman
About Dan Wildman
Dan Wildman is a seasoned board member and medical device industry professional with over 40 years of experience. He has held various leadership roles at Johnson & Johnson and currently serves as an Independent Director at Nyxoah and Chairman of the Board at Progenerative Medical, Inc.
Work at PanTher Therapeutics
Dan Wildman currently serves as an Independent Director at PanTher Therapeutics, a position he has held since 2023. Prior to this role, he was a Strategic Advisor for the company from 2022 to 2023. His involvement with PanTher Therapeutics reflects his extensive experience in the medical device industry, particularly in the commercialization of innovative technologies.
Current Positions in the Medical Device Industry
In addition to his role at PanTher Therapeutics, Dan Wildman is currently a Director at UroGen Pharma, a position he has held since 2022. He also serves as the Chairman of the Board at Progenerative Medical, Inc. since 2022. Furthermore, he has been an Independent Director at Nyxoah since 2023. These roles highlight his active engagement in advancing medical technologies.
Experience at Johnson & Johnson
Dan Wildman has a significant history with Johnson & Johnson, where he held multiple leadership roles over more than a decade. His positions included Worldwide President of Ethicon Biosurgery from 2003 to 2014, WW President of Depuy Synthes Spine from 2015 to 2017, and President of several divisions, including Closure Medical and Omrix Biopharmaceuticals. His tenure at Johnson & Johnson contributed to his expertise in the medical device sector.
Education and Expertise
Dan Wildman earned a Bachelor of Science degree in Economics from St. Lawrence University, where he studied from 1974 to 1978. With over 40 years of experience in the medical device industry, he has developed a strong expertise in the global commercialization of novel and complex technologies, including combination drug/device products.
Background and Leadership Roles
Based in Wellington, Florida, Dan Wildman has held various leadership positions throughout his career, including VP of Strategic Marketing at Boston Scientific and various executive roles at Johnson & Johnson. His leadership experience spans multiple sectors within the medical device industry, underscoring his capability to drive innovation and growth.